Announcements

  • a group of clinicians looking at data

    Our cross-journal Collection welcomes submissions of papers reporting interventional trials - we will consider phase I to phase IV clinical trials - including those yielding negative results for which primary end-points were not met. We are particularly interested in studies first reporting primary and secondary outcomes of interventional clinical trials.

    Open for submissions
  • blood cells in the blood vessle

    Our cross-journal Collection invites manuscripts that highlight new point-of-care diagnostic tools, host-response profiling to predict disease trajectory, novel biomarkers to distinguish from other inflammatory conditions, as well as the latest insights into effective care and treatment for sepsis patients. We also aim to support research into low-resource adaptations of existing sepsis protocols

    Open for submissions
  • doctors looking at kidney cartoon

    Our cross-journal Collection aims to bring together the current advances in renal health, including topics of interest such as: Novel biomarkers for early diagnosis, Genetic predisposition to kidney disease, Impact of lifestyle interventions on kidney health and function, Innovative treatment strategies in nephrology, including precision medicine, regenerative medicine, and gene editing.

    Open for submissions
  • village in flood

    This cross-journal Collection invites submissions that explore the clinical and genetic dimensions of climate-sensitive infectious diseases.

    Open for submissions

Advertisement

  • Xiong et al. discuss the Data Science for Health Discovery and Innovation in Africa, a US-Africa partnership aiming to transform health via innovative data science. Achievements to date include 38 projects in 22 African countries, an open FAIR data ecosystem, and AI tools for disease management and pandemic preparedness.

    • Chenfeng Xiong
    • Joyce Nakatumba Nabende
    • Mayowa Owolabi
    CommentOpen Access
  • Daou et al. advocate for the integration of conflict-responsive training into healthcare education across low- and middle-income countries to better prepare professionals to deliver care in conflict-affected, resource-limited settings. Drawing on expert dialogues and field-based insights, they outline practical pathways for curricular reform grounded in local realities to help institutions design contextually relevant curricula."

    • Tracy Daou
    • Nisrine El Hadi
    • Shadi Saleh
    CommentOpen Access
  • Personalized Medicine was designed with a scientific framework that considered both the disease and the person with the disease. Here, we illustrate that the current approach to Personalized Medicine has neglected the person and offers a pathway to restoring the essential importance of the person’s lived experience.

    • Ralph I. Horwitz
    • Allison Hayes Conroy
    • Ida Sim
    CommentOpen Access
  • Amid continuous innovation in sequencing and gene-editing technologies combined with enhanced understanding of RNA biology, there has been an increase in RNA-based technologies for the treatment of a wide array of diseases. We discuss some recent work in the field, highlighting the RNA biology and RNA-based applications to medicine collection, which showcases the versatility of RNA for filling numerous gaps in disease treatment and detection.

    • Catherine A. Freije
    • Virginia Arechavala-Gomeza
    EditorialOpen Access
Stem cell treatment and biology as a multicellular embryonic concept or adult organismas a symbol for cellular therapy as a 3D illustration.

Stem cell-derived therapies

This cross-journal Collection welcomes submissions that explore stem cell biology, their therapeutic potential, and the use of stem cells and stem cell-derived products to treat human disease.
Collection

Advertisement